Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Pharmaceutical Business Review
Return to: PBR Home
Search Refinements

News

View news from other Pharmaceutical sectors:
136-150 of 50010 results
GSK seeks EU approval for inhaled triple combo COPD therapy
By PBR Staff Writer
GlaxoSmithKline (GSK) is seeking approval in Europe for once-daily closed triple combination therapy to treat chronic obstructive pulmonary disease (COPD) patients.
News
FDA approves cardiovascular indication for Jardiance
By PBR Staff Writer
The US Food and Drug Administration (FDA) has approved a new indication for Jardiance (empagliflozin), a type 2 diabetes treatment from Boehringer Ingelheim and Eli Lilly.
Regulatory Affairs > News
Agilis' AADC gene therapy candidate gets OMP designation in Europe
Agilis Biotherapeutics’ gene therapy product candidate, AGIL-AADC has secured Orphan Medicinal Product (OMP) designation from the European Commission (EC).
Production & Manufacturing > Process & Production > News
ACADIA begins phase 2 trial of Nuplazid in major depressive disorder
ACADIA Pharmaceuticals has started a Phase II study dubbed CLARITY to evaluate pimavanserin for adjunctive treatment in patients with major depressive disorder (MDD) who have an inadequate response to first-line therapies for clinical depression.
Contract Research & Services > Clinical Trials > News
Daiichi Sankyo’s breast cancer drug candidate gets FDA fast track designation
Daiichi Sankyo has secured fast track designation from the US Food and Drug Administration (FDA) for its investigational HER2-targeting antibody drug conjugate DS-8201 for the treatment of HER2-positive unresectable and/or metastatic breast cancer in patients who have progressed after prior treatment with HER2-targeted therapies including ado-trastuzumab emtansine (T-DM1).
Production & Manufacturing > Process & Production > News
Bicycle, AstraZeneca enter into potential $1bn multitarget collaboration
By PBR Staff Writer
Bicycle Therapeutics and AstraZeneca have agreed a $1bn multi-target collaboration across respiratory, cardiovascular and metabolic diseases.
Drug Research > Drug Discovery & Development > News
Pfizer, IBM partner to advance immuno-oncology research
By PBR Staff Writer
Pharmaceutical major Pfizer and technology giant IBM have partnered to accelerate immuno-oncology research.
Automation > IT & Software > News
Heptares to buy G7 Therapeutics to expand GPCR capabilities
By PBR Staff Writer
Sosei Group's subsidiary Heptares Therapeutics has agreed to acquire Swiss drugmaker G7 Therapeutics for CHF12m ($11.8m).
Production & Manufacturing > Manufacturing > News
Natrix collaborates with Merck and Sanofi on Protein A Platform
Natrix Separations has signed development agreements with Merck and Sanofi to advance its new membrane-based Protein A platform for antibody purification.
Contract Research & Services > Contract Services > News
AbbVie’s risankizumab secures FDA orphan drug status for paediatric Crohn’s
AbbVie has secured Orphan Drug Designation from the US Food and Drug Administration (FDA) to risankizumab (ABBV-066; formerly BI 655066) for the investigational treatment of Crohn's disease in pediatric patients.
Production & Manufacturing > Process & Production > News
Evotec, Merck sign deals to partner on target discovery technologies
Evotec and Merck have signed agreements to collaborate on target discovery technologies.
Drug Research > Drug Discovery & Development > News
Pfizer's Herceptin biosimilar succeeds in breast cancer study
By PBR Staff Writer
A clinical trial comparing the safety and efficacy of Pfizer's biosimilar PF-05280014 to Roche's Herceptin met the primary endpoint in a breast cancer trial.
Contract Research & Services > Clinical Trials > News
Takeda to establish dengue vaccine manufacturing facility in Germany
By PBR Staff Writer
Takeda Pharmaceutical is investing over €100m to build a new dengue vaccine manufacturing facility in Singen, Germany.
Production & Manufacturing > Manufacturing > News
West Pharmaceutical Services expands contract manufacturing capabilities in Ireland
West Pharmaceutical Services has completed a 60,000ft² expansion at its contract manufacturing facility near Mulhuddart, County Dublin, Ireland.
Production & Manufacturing > Manufacturing > News
OxThera raises EUR32m to complete Oxabact development to treat primary hyperoxaluria
Swedish privately-held biopharmaceutical firm OxThera has raised EUR32m to complete development of Oxabact for the treatment of primary hyperoxaluria.
Drug Research > Drug Discovery & Development > News
136-150 of 50010 results